Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results ...

Veru (VERU) announced positive topline results from the Phase 2b QUALITY clinical study. The Phase 2b QUALITY clinical study was ...

Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay ...

A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose management, weight loss and lower insulin requirements. Semaglutide (known by its ...

Wegovy (semaglutide) is a prescription drug used for weight management and heart disease related to obesity. Wegovy can cause side effects that range from mild to serious. Examples include ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

What are the running costs? The MG4 EV is incredibly good value to buy. Not only is it thousands cheaper than similarly sized rivals, but it has also more standard equipment and is much cheaper on a ...

Both tirzepatide and semaglutide are commercially available. Patients taking liraglutide (3 mg once-daily injection), also on the market, lost up to 6% of body weight after 26 weeks. The authors ...

The 41.9 kWh battery pack in Chevrolet Spark EUV spied testing, is rated to deliver around 400 km on a single charge (CLTC cycle) You might be familiar with the Yep 3-Door and Yep Plus 5-Door ...

The EMA is reviewing Danish studies linking semaglutide to increased NAION risk, following a request from the Danish Medicines Agency. Semaglutide, a GLP-1 receptor agonist, is approved for obesity ...